125 related articles for article (PubMed ID: 17192474)
1. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta.
Gross ER; Hsu AK; Gross GJ
Diabetes; 2007 Jan; 56(1):127-36. PubMed ID: 17192474
[TBL] [Abstract][Full Text] [Related]
2. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
[TBL] [Abstract][Full Text] [Related]
3. Diabetes abolishes the cardioprotection induced by sevoflurane postconditioning in the rat heart in vivo: roles of glycogen synthase kinase-3β and its upstream pathways.
Tai W; Shi E; Yan L; Jiang X; Ma H; Ai C
J Surg Res; 2012 Nov; 178(1):96-104. PubMed ID: 22482760
[TBL] [Abstract][Full Text] [Related]
4. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta.
Gross ER; Hsu AK; Gross GJ
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H827-34. PubMed ID: 16517948
[TBL] [Abstract][Full Text] [Related]
5. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia/reperfusion injury by altering glycogen synthase kinase-3β.
Chen QL; Gu EW; Zhang L; Cao YY; Zhu Y; Fang WP
Acta Anaesthesiol Scand; 2013 Feb; 57(2):236-42. PubMed ID: 22881281
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
8. GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
Gross ER; Hsu AK; Gross GJ
Basic Res Cardiol; 2007 Jul; 102(4):341-9. PubMed ID: 17450314
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
[TBL] [Abstract][Full Text] [Related]
10. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal.
Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH
Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545
[TBL] [Abstract][Full Text] [Related]
11. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.
Gross ER; Hsu AK; Gross GJ
Circ Res; 2004 Apr; 94(7):960-6. PubMed ID: 14976126
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways.
Xue R; Lei S; Xia ZY; Wu Y; Meng Q; Zhan L; Su W; Liu H; Xu J; Liu Z; Zhou B; Xia Z
Clin Sci (Lond); 2016 Mar; 130(5):377-92. PubMed ID: 26666444
[TBL] [Abstract][Full Text] [Related]
13. Hypercholesterolemia blocked sevoflurane-induced cardioprotection against ischemia-reperfusion injury by alteration of the MG53/RISK/GSK3β signaling.
Ma LL; Zhang FJ; Qian LB; Kong FJ; Sun JF; Zhou C; Peng YN; Xu HJ; Wang WN; Wen CY; Zhu MH; Chen G; Yu LN; Liu XB; Wang JA; Yan M
Int J Cardiol; 2013 Oct; 168(4):3671-8. PubMed ID: 23856444
[TBL] [Abstract][Full Text] [Related]
14. Morphine Reduces Myocardial Infarct Size via Heat Shock Protein 90 in Rodents.
Small BA; Lu Y; Hsu AK; Gross GJ; Gross ER
Biomed Res Int; 2015; 2015():129612. PubMed ID: 26413502
[TBL] [Abstract][Full Text] [Related]
15. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
Mozaffari MS; Schaffer SW
Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
[TBL] [Abstract][Full Text] [Related]
16. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta.
Nishihara M; Miura T; Miki T; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Ohori K; Takahashi A; Shimamoto K
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H748-55. PubMed ID: 16565311
[TBL] [Abstract][Full Text] [Related]
18. Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart.
Yadav HN; Singh M; Sharma PL
Mol Cell Biochem; 2010 Oct; 343(1-2):75-81. PubMed ID: 20512612
[TBL] [Abstract][Full Text] [Related]
19. The synthetic pentasaccharide fondaparinux attenuates myocardial ischemia-reperfusion injury in rats via STAT-3.
Macchi L; Moussa WB; Guillou S; Tamareille S; Lamon D; Prunier D; Prunier F
Shock; 2014 Feb; 41(2):166-71. PubMed ID: 24300830
[TBL] [Abstract][Full Text] [Related]
20. [Ischemic postconditioning attenuates ischemia/reperfusion injury in isolated hypertrophied rat heart].
Peng LY; Ma H; He JG; Gao XR; Zhang Y; He XH; Zhai YS; Zhang XJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):685-9. PubMed ID: 17081389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
